Medical Supplierz Expands Online Access to Surgical and Diagnostic Equipment
'We're building a digital gateway for global healthcare, empowering suppliers to scale faster and giving providers seamless access to advanced surgical and diagnostic solutions.' — Bader Alajeel, CEO of Medical Supplierz
KUWAIT, KUWAIT, June 30, 2025 / EINPresswire.com / -- Medical Supplierz has expanded its digital marketplace to streamline the purchase of diagnostic and surgical equipment for healthcare providers globally. This initiative addresses the growing need for efficient and transparent procurement in a rapidly evolving healthcare landscape, where timely access to quality equipment is critical for operational success and patient care.
The platform provides hospitals, clinics, and procurement agencies with centralized access to a wide range of verified diagnostic and surgical tools—from imaging devices and laboratory analyzers to surgical kits and operating room instruments. By enabling direct interaction between buyers and global suppliers, Medical Supplierz removes the dependency on intermediaries and reduces delays commonly associated with international sourcing.
Buyers on the platform can browse categorized listings, review technical specifications, and initiate transactions through a secure, user-friendly interface. The system is designed with compliance in mind, allowing users to verify certifications, access product documentation, and ensure adherence to local import standards. These features are particularly valuable for institutions seeking to maintain regulatory integrity while sourcing from diverse markets.
In addition to improving access for buyers, the platform empowers suppliers by offering a streamlined way to reach verified healthcare procurement teams across multiple countries. This is especially beneficial for manufacturers aiming to enter or grow in markets where establishing physical sales networks is challenging. Medical Supplierz provides these suppliers with digital visibility and the tools needed to manage inquiries and monitor demand across different regions.
The platform has seen growing interest from medical institutions in regions such as the Middle East, Southeast Asia, and parts of Africa—areas that are actively expanding their healthcare infrastructure and investing in diagnostic and surgical technologies. As demand rises, the platform's role in connecting trusted suppliers with capable buyers becomes increasingly important for global healthcare delivery.
About Medical Supplierz:
Medical Supplierz is a global B2B marketplace designed specifically for the healthcare industry. It connects manufacturers and distributors of medical equipment with verified institutional buyers, offering a secure and scalable digital procurement solution. The platform supports the exchange of a wide range of medical products, including diagnostics, surgical tools, and hospital equipment.
Homod Falah Alshemmri
Medical Supplierz
+965 9408 9218
email us here
Visit us on social media:
LinkedIn
Instagram
Facebook
YouTube
X
Legal Disclaimer:
EIN Presswire provides this news content 'as is' without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
20 minutes ago
- Yahoo
Undiscovered Gems In The Middle East To Watch This June 2025
As Middle Eastern markets experience a surge, with Gulf shares climbing amid the Israel-Iran ceasefire and Dubai reaching a 17-year high, investors are increasingly turning their attention to potential opportunities in this dynamic region. In such an environment, identifying stocks that demonstrate strong fundamentals and resilience can be key to navigating these promising yet complex markets. Name Debt To Equity Revenue Growth Earnings Growth Health Rating Sure Global Tech NA 11.95% 18.65% ★★★★★★ MOBI Industry 6.50% 5.60% 24.00% ★★★★★★ Besler Gida Ve Kimya Sanayi ve Ticaret Anonim Sirketi 40.12% 43.54% 38.87% ★★★★★★ Vakif Gayrimenkul Yatirim Ortakligi 0.00% 50.97% 56.63% ★★★★★★ Gür-Sel Turizm Tasimacilik ve Servis Ticaret 6.88% 51.77% 67.59% ★★★★★☆ MIA Teknoloji Anonim Sirketi 17.80% 49.41% 66.89% ★★★★★☆ Segmen Kardesler Gida Üretim ve Ambalaj Sanayi Anonim Sirketi 2.02% -10.23% 74.54% ★★★★☆☆ Kirac Galvaniz Telekominikasyon Metal Makine Insaat Elektrik Sanayi ve Ticaret Anonim Sirketi 12.49% -23.32% 41.51% ★★★★☆☆ Dogan Burda Dergi Yayincilik Ve Pazarlama 64.82% 46.23% -12.39% ★★★★☆☆ Izmir Firça Sanayi ve Ticaret Anonim Sirketi 43.01% 40.80% -34.83% ★★★★☆☆ Click here to see the full list of 218 stocks from our Middle Eastern Undiscovered Gems With Strong Fundamentals screener. Let's uncover some gems from our specialized screener. Simply Wall St Value Rating: ★★★★☆☆ Overview: Izmir Firça Sanayi ve Ticaret Anonim Sirketi is engaged in the production and sale of various cleaning materials and painting brushes both in Turkey and internationally, with a market capitalization of TRY10.34 billion. Operations: Izmir Firça generates revenue primarily from its Building Products segment, amounting to TRY323.37 million. The company's financial performance is characterized by its gross profit margin trend, which provides insights into its cost management and pricing strategies. Izmir Firça Sanayi ve Ticaret Anonim Sirketi has seen its debt to equity ratio improve significantly, dropping from 100.8% to 43% over the past five years. Despite this progress, the company reported a net loss of TRY 21.18 million for Q1 2025, widening from TRY 13.07 million the previous year, with sales falling to TRY 86.52 million from TRY 117.6 million a year ago. Interest payments are well covered by EBIT at five times coverage, indicating financial stability in that area; however, free cash flow remains negative and operating cash flow does not cover debt adequately, highlighting areas for potential improvement moving forward. Unlock comprehensive insights into our analysis of Izmir Firça Sanayi ve Ticaret Anonim Sirketi stock in this health report. Learn about Izmir Firça Sanayi ve Ticaret Anonim Sirketi's historical performance. Simply Wall St Value Rating: ★★★★★★ Overview: Hilan Ltd. is a software as a service (SaaS) provider that develops solutions for enterprise human capital management in Israel, with a market capitalization of ₪6.51 billion. Operations: Hilan generates revenue primarily from Business Information Services (₪1.67 billion), Marketing of Software Products (₪391.95 million), Payroll Services, Human Resources and Organizational Systems (₪539.03 million), and Computer Infrastructure (₪322.35 million). Hilan, a nimble player in the Middle East's professional services sector, has demonstrated robust financial health and growth. Over the past year, earnings surged by 14%, outpacing the industry's 10.9% rise. The company is trading at a significant discount of 42.3% below its estimated fair value, suggesting potential for appreciation. Hilan's debt situation appears strong with more cash than total debt and a reduced debt-to-equity ratio from 33.9% to just 3.4% over five years. Recent results show sales climbing to ILS 782 million from ILS 709 million last year, with net income reaching ILS 66 million up from ILS 58 million previously. Take a closer look at Hilan's potential here in our health report. Gain insights into Hilan's past trends and performance with our Past report. Simply Wall St Value Rating: ★★★★☆☆ Overview: Isrotel Ltd. operates and manages a chain of hotels in Israel with a market capitalization of ₪5.32 billion. Operations: The company generates revenue primarily from its Hotels & Motels segment, which reported earnings of ₪1.96 billion. Isrotel, a notable player in the hospitality sector, has demonstrated resilience with its net debt to equity ratio at 17.2%, deemed satisfactory. Over the past year, earnings grew by 6.8%, outpacing the broader hospitality industry's -6.5%. The company's interest payments are well covered by EBIT at a robust 24.1x coverage, indicating financial stability despite recent challenges reflected in a drop in quarterly net income to ILS 2.13 million from ILS 27.76 million last year. With high-quality past earnings and positive free cash flow, Isrotel stands as a promising investment opportunity amidst current market conditions. Click here to discover the nuances of Isrotel with our detailed analytical health report. Review our historical performance report to gain insights into Isrotel's's past performance. Click through to start exploring the rest of the 215 Middle Eastern Undiscovered Gems With Strong Fundamentals now. Are you invested in these stocks already? Keep abreast of every twist and turn by setting up a portfolio with Simply Wall St, where we make it simple for investors like you to stay informed and proactive. Streamline your investment strategy with Simply Wall St's app for free and benefit from extensive research on stocks across all corners of the world. Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management. Find companies with promising cash flow potential yet trading below their fair value. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include IBSE:IZFAS TASE:HLAN and TASE:ISRO. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Sign in to access your portfolio
Medscape
34 minutes ago
- Medscape
Tool Predicts if Seniors with Cancer Can Stay Home Post Op
TOPLINE: A novel predictive model named STAYHOME effectively estimated the risk of losing the ability to live at home among older adults after cancer surgery, demonstrating good calibration with minimal deviation from observed risks. The model predicted a 2.4% and 3.4% risk for admission to a nursing home at 6 months and 12 months, respectively. METHODOLOGY: Older adults prioritize long-term functional independence, and the ability to return and stay at home after cancer surgery remains a key concern. However, current prognostic tools focus on short-term outcomes, lacking individualized long-term risk estimates. To estimate the risk of losing the ability to live at home post-surgery, researchers developed and internally validated a risk prediction model, named STAYHOME, among 97,353 community-dwelling older adults (median age, 76 years) who underwent cancer surgery between 2007 and 2019. The predictive model included preoperative variables such as age, sex, rural residence, previous cancer diagnosis, surgery type, frailty, receipt of home care support, receipt of neoadjuvant therapy, cancer site, and cancer stage. The primary outcome was the inability to stay at home after cancer surgery, defined as the time to admission to a nursing home, and was measured at 6 months and 12 months. TAKEAWAY: Overall, 2658 patients (2.7%) at 6 months and 3746 (3.8%) at 12 months were admitted to a nursing home post-surgery. The mean predicted risk of not staying home was 2.4% at 6 months and 3.4% at 12 months. The STAYHOME tool demonstrated a strong predictive capability, with areas under the curve of 0.76 and 0.75 for 6- and 12-month predictions, respectively. The tool also demonstrated minimal deviation from the observed risk for 6-month (0.33 percentage point on average; calibration slope, 1.27) and 12-month (0.46 percentage point on average; calibration slope, 1.17) predictions. The model's calibration was excellent for most predictors at 6 months and 12 months, with a deviation of < 0.8 percentage points from the observed probability; only age older than 85 years (1.13%), preoperative frailty (1.16%), and receipt of preoperative home care support (1.25%) exceeded the deviation of 1 percentage point at 12 months. Across risk deciles, deviations between predicted and observed probabilities were 0.1%-1.5% at 6 months and 0.1%-1.9% at 12 months, reflecting good calibration. The deviation for the slight overestimation at or above the seventh decile remained under 2% for both timepoints. IN PRACTICE: 'The STAYHOME tool demonstrated good discrimination and was well calibrated. Thus, it may be a useful tool to identify a specific group of individuals at risk of not remaining home,' the authors wrote. '[The tool] used information readily available to patients, care partners, and healthcare professionals and may be implemented to provide them with individualized risk estimates and improve surgical oncology care delivery and experience for older adults,' they concluded. SOURCE: This study, led by Julie Hallet, MD, Odette Cancer Centre, Sunnybrook Health Sciences Centre in Toronto, Ontario, Canada, was published online in JAMA Surgery. LIMITATIONS: The STAYHOME tool showed slightly reduced discrimination for predictor levels of preoperative frailty, preoperative home care use, receipt of neoadjuvant therapy, and having stage IV disease. The model was also less well calibrated at the extremes of the risk distribution, with a slight overestimation in higher-risk categories. DISCLOSURES: This study was funded by operating grants from the Canadian Institutes for Health Research, Ontario Cancer Research Institute, and ICES. One author reported receiving speaker fees from Ipsen, outside the submitted work. This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.
Bloomberg
44 minutes ago
- Bloomberg
Dubai Property More Affordable Than London, New York
Live on Bloomberg TV CC-Transcript 00:00Now turning to the UAE, because despite its record of managing to thrive during global instability, the Iran Israel confrontation does pose one of the most stringent tests yet for the countries neutral and open for business stance. We can get more on this with Clementine Monaro, whose House and House sales director. Clementine, it's really good to have you with me. Thank you so much for stopping in. This conflict, I feel must have been the first time for a whole generation of ex-pats that they've been exposed to the risks in the Middle East, particularly when you had those strikes on the US airbase in Qatar. Do you think that it's going to have a lasting impact on sentiment in the region of people living here and moving here? Investment sentiment as well, that for the first time they've had to really think about their safety? I think last week certainly there were some uncomfortable conversations that we were having, both as management, how do we empower our team to have conversations with buyers and sellers? But the reality is when there is geopolitical instability in the region, it only makes Dubai look safer. Yeah, and anecdotally, house and House Holiday Homes Department had a huge increase in Iranians seeking shelter in Dubai. Okay, that's really interesting. So Dubai is seen as a safe haven and that continues. Maybe this is even beneficial. What's been driving Dubai's continued price growth then? This has been the underlying trend, even amid the global headwinds, even amid the, say, for dollar soft dollar as well. I think Dubai is just an incredibly safe place to want to be. The Times reports at 16 and a half thousand millionaires have left the UK and 9800 of those have landed into Dubai. And I think what that is talking of is just brilliant infrastructure. The ease of doing business here just is seen as a really safe place to come. We mentioned the UK. I wonder with my UK correspondent hat on how much that's to do with Dubai benefiting from the Labour government in the UK dismantling the non-dom regime? Absolutely. But that's definitely what we're seeing. And even just the education now here has really caught up health care. I think people, even with things like the private school fees, VAT that went on, still much cheaper to educate your children here and yet arguably you're getting the similar quality of education. And so you're forecasting for that trend to continue. We are okay because that's a real worry for the Chancellor if more than one in four non-dom actually leave the UK. So that's really interesting. And then how does Dubai actually stack up globally when it comes to value and investor appeal? Because of course there are lots of cities where the non-dom is, but other rich and mobile people could go nuts. It Dubai is still so affordable to buy blends out an average of $418 per square foot. If you look, that's nearly half of Paris, which is $700 per square foot. And then London, 1400 dollars a square foot. New York, 1650, Singapore topping out at 1750. So it's almost four times cheaper to live in Dubai than it is in London. And that's not including the fact that you're also not paying tax on your income here. And is it the luxury segment that's driving things or is it also the mass segment? And how does it pan out? I mean, those are those numbers are over a blended average. But what we are seeing is that the mid level has been pretty buoyant, although with the supply that's coming in the next couple of years. That's a segment to watch. But the prime segment is absolutely flying.
